These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions. Yeo KT; Wang HH; Nagy JA; Sioussat TM; Ledbetter SR; Hoogewerf AJ; Zhou Y; Masse EM; Senger DR; Dvorak HF Cancer Res; 1993 Jun; 53(12):2912-8. PubMed ID: 8504432 [TBL] [Abstract][Full Text] [Related]
11. Partial purification and characterization of a vascular permeability factor secreted by a human colon adenocarcinoma cell line. Lobb RR; Key ME; Alderman EM; Fett JW Int J Cancer; 1985 Oct; 36(4):473-8. PubMed ID: 4044056 [TBL] [Abstract][Full Text] [Related]
12. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation. Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721 [TBL] [Abstract][Full Text] [Related]
13. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Brown LF; Berse B; Jackman RW; Tognazzi K; Manseau EJ; Senger DR; Dvorak HF Cancer Res; 1993 Oct; 53(19):4727-35. PubMed ID: 8402650 [TBL] [Abstract][Full Text] [Related]
14. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms. Abu-Jawdeh GM; Faix JD; Niloff J; Tognazzi K; Manseau E; Dvorak HF; Brown LF Lab Invest; 1996 Jun; 74(6):1105-15. PubMed ID: 8667614 [TBL] [Abstract][Full Text] [Related]
15. The in vivo bioactivity of vascular endothelial growth factor/vascular permeability factor is independent of N-linked glycosylation. Walter DH; Hink U; Asahara T; Van Belle E; Horowitz J; Tsurumi Y; Vandlen R; Heinsohn H; Keyt B; Ferrara N; Symes JF; Isner JM Lab Invest; 1996 Feb; 74(2):546-56. PubMed ID: 8780172 [TBL] [Abstract][Full Text] [Related]
17. A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Senger DR; Perruzzi CA; Feder J; Dvorak HF Cancer Res; 1986 Nov; 46(11):5629-32. PubMed ID: 3756910 [TBL] [Abstract][Full Text] [Related]
18. Significance of vascular endothelial growth factor/vascular permeability factor for solid tumor growth, and its inhibition by the antibody. Kondo S; Asano M; Suzuki H Biochem Biophys Res Commun; 1993 Aug; 194(3):1234-41. PubMed ID: 7688963 [TBL] [Abstract][Full Text] [Related]
19. Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) delays and induces escape from senescence in human dermal microvascular endothelial cells. Watanabe Y; Lee SW; Detmar M; Ajioka I; Dvorak HF Oncogene; 1997 May; 14(17):2025-32. PubMed ID: 9160882 [TBL] [Abstract][Full Text] [Related]
20. Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. Clauss M; Gerlach M; Gerlach H; Brett J; Wang F; Familletti PC; Pan YC; Olander JV; Connolly DT; Stern D J Exp Med; 1990 Dec; 172(6):1535-45. PubMed ID: 2258694 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]